Tender detail

Joint procurement of medicinal products containing glecaprevir and pibrentasvir 2026

Summary

Olomouc University Hospital and Ostrava University Hospital are jointly procuring recurring supplies of medicinal products containing the active substances glecaprevir and pibrentasvir. The products must meet the requirements of the Czech State Institute for Drug Control. The estimated contract value is CZK 64,934,100, and the planned contract period is 48 months.

Reference number
793214-2026
Buyer
Fakultní nemocnice Olomouc
Country
Czechia (CZE)
Procedure
Open procedure
CPV
33651400 Antivirals for systemic use
Deadline
2026-12-18
Status
Open
Contract subject
Supplies
Estimated value
64 934 100,00 CZK
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.